Sci Transl Med.:新技术快速检测脑肿瘤

2013-09-09 EurekAlert!中文 EurekAlert!中文

一种检测细胞中蛋白质和脂质量的新技术可帮助外科医生发现肉眼无法看到的脑肿瘤组织。目前,脑手术牵涉到许多的猜测。因为很难区分脑肿瘤与正常脑组织,神经外科医生常常在手术时依赖像组织颜色和质地等可见的线索。在许多手术中,本来可以被安全去除的肿瘤组织却意外地被留了下来。由Daniel Orringer及其同事研发的新技术依靠拉曼光谱检测法,它能通过检测化学键的振动来对组织中的脂质和蛋白质的丰富程度进行

一种检测细胞中蛋白质和脂质量的新技术可帮助外科医生发现肉眼无法看到的脑肿瘤组织。目前,脑手术牵涉到许多的猜测。因为很难区分脑肿瘤与正常脑组织,神经外科医生常常在手术时依赖像组织颜色和质地等可见的线索。在许多手术中,本来可以被安全去除的肿瘤组织却意外地被留了下来。由Daniel Orringer及其同事研发的新技术依靠拉曼光谱检测法,它能通过检测化学键的振动来对组织中的脂质和蛋白质的丰富程度进行测绘。肿瘤有着相对较高含量的蛋白及相对较低的脂质,而正常脑组织则两者皆含量丰富。Orringer及其同事应用一种特殊的高功率类型的拉曼光谱检测法——叫做受激拉曼散射或SRS,它能让研究人员快速地对小鼠中的脑肿瘤成像。

为了给图像添加色彩,研究人员对拉曼信号进行编码——使脂质呈绿色,蛋白呈蓝色,因此肿瘤看上去大多呈蓝色而正常组织则显示大量的绿色。正如所料,他们看到癌细胞在组织中紧密地挤在一起并观察到束状的轴突——即长的纤维状的神经元——会像高速公路那样帮助癌细胞在大脑的各处穿行。研究人员还在脑手术时将SRS应用于活体小鼠并展示,SRS可在活体脑的区域中给肿瘤成像,而在这些区域中肿瘤组织对肉眼来说看上去是正常的。在肿瘤与正常组织之间的边缘地带,研究人员看到有细胞(推测是肿瘤细胞)向正常脑组织渗透。Orringer及其同事目前正在构建一种基于SRS成像的牙刷大小的手持式探头,神经外科医生在手术时有可能会无需除去组织而对脑组织进行分析。生物谷(Bioon.com)

生物谷推荐的英文摘要

Cover

Sci. Transl. Med. DOI: 10.1126/scitranslmed.3005954

Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy

Minbiao Ji1,*, Daniel A. Orringer2,*, Christian W. Freudiger1, Shakti Ramkissoon3,4, Xiaohui Liu5, Darryl Lau2, Alexandra J. Golby5,6, Isaiah Norton5, Marika Hayashi4, Nathalie Y. R. Agar5,6, Geoffrey S. Young6, Cathie Spino7, Sandro Santagata3, Sandra Camelo-Piragua8, Keith L. Ligon3,4,9, Oren Sagher2 and X. Sunney Xie1,†

Surgery is an essential component in the treatment of brain tumors. However, delineating tumor from normal brain remains a major challenge. We describe the use of stimulated Raman scattering (SRS) microscopy for differentiating healthy human and mouse brain tissue from tumor-infiltrated brain based on histoarchitectural and biochemical differences. Unlike traditional histopathology, SRS is a label-free technique that can be rapidly performed in situ. SRS microscopy was able to differentiate tumor from nonneoplastic tissue in an infiltrative human glioblastoma xenograft mouse model based on their different Raman spectra. We further demonstrated a correlation between SRS and hematoxylin and eosin microscopy for detection of glioma infiltration (κ = 0.98). Finally, we applied SRS microscopy in vivo in mice during surgery to reveal tumor margins that were undetectable under standard operative conditions. By providing rapid intraoperative assessment of brain tissue, SRS microscopy may ultimately improve the safety and accuracy of surgeries where tumor boundaries are visually indistinct.

原文下载

Ji M, Orringer DA, Freudiger CW, Ramkissoon S, Liu X, Lau D, Golby AJ, Norton I, Hayashi M, Agar NY, Young GS, Spino C, Santagata S, Camelo-Piragua S, Ligon KL, Sagher O, Xie XS.Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy.Sci Transl Med. 2013 Sep 4;5(201):201ra119.

 

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1903656, encodeId=88d3190365631, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Mon Nov 04 17:26:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656585, encodeId=af9b1656585a2, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 22 11:26:00 CST 2014, time=2014-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067130, encodeId=d0f7206e130ae, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Apr 29 09:26:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417985, encodeId=fa3b141e985dd, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606020, encodeId=8e05160602095, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1903656, encodeId=88d3190365631, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Mon Nov 04 17:26:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656585, encodeId=af9b1656585a2, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 22 11:26:00 CST 2014, time=2014-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067130, encodeId=d0f7206e130ae, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Apr 29 09:26:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417985, encodeId=fa3b141e985dd, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606020, encodeId=8e05160602095, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
    2014-02-22 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=1903656, encodeId=88d3190365631, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Mon Nov 04 17:26:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656585, encodeId=af9b1656585a2, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 22 11:26:00 CST 2014, time=2014-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067130, encodeId=d0f7206e130ae, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Apr 29 09:26:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417985, encodeId=fa3b141e985dd, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606020, encodeId=8e05160602095, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1903656, encodeId=88d3190365631, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Mon Nov 04 17:26:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656585, encodeId=af9b1656585a2, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 22 11:26:00 CST 2014, time=2014-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067130, encodeId=d0f7206e130ae, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Apr 29 09:26:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417985, encodeId=fa3b141e985dd, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606020, encodeId=8e05160602095, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1903656, encodeId=88d3190365631, content=<a href='/topic/show?id=be285836438' target=_blank style='color:#2F92EE;'>#新技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58364, encryptionId=be285836438, topicName=新技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d39f177, createdName=lixiao3326, createdTime=Mon Nov 04 17:26:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656585, encodeId=af9b1656585a2, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sat Feb 22 11:26:00 CST 2014, time=2014-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067130, encodeId=d0f7206e130ae, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Apr 29 09:26:00 CST 2014, time=2014-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417985, encodeId=fa3b141e985dd, content=<a href='/topic/show?id=6ba485016cd' target=_blank style='color:#2F92EE;'>#脑肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85016, encryptionId=6ba485016cd, topicName=脑肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f03326658, createdName=839640779, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606020, encodeId=8e05160602095, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 11 06:26:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]

相关威廉亚洲官网

JNCI:血管内皮蛋白酪氨酸磷酸酶抑制有助于肿瘤血管结构和功能正常化

血管内皮蛋白酪氨酸磷酸酶抑制可使肿瘤血管的结构和功能正常化。 实体瘤结构和功能异常的特征在于其微血管形成,并且微血管形成介导了数种有害的肿瘤行为。血管内皮蛋白酪氨酸磷酸酶(VE-PTP)是一种抑制内皮细胞Tie-2受体酪氨酸激酶的物质,在本研究中,为了确定VE-PTP对阻碍肿瘤血管成熟所起的作用,来自美国哈佛医学院的Shom Goel等设计了相关研究,研究结果发表在JNCI 8月的在线期刊上。

2013年国家自然科学基金医学类肿瘤学获批最多

医学类独占鳌头项目数6985项,占总项目数的25%,获批项目金额也是最高,达到367041.2万元,占总金额23.3%。 从获批情况来看,肿瘤学最多,获批1531项,获批金额达79289.50。占获批总数和获批金额总数分别是22%,21.6% 表:医学类获批项目情况 学科名 项目数

自闭症可能与肿瘤基因相关

从表面上来看,自闭症和肿瘤是两种风马牛不相及的疾病。然而,研究这两种疾病的科学家们却意外地得出了同一个惊人的发现:某些自闭症患者携带有突变型的癌症或肿瘤基因,很可能正是这些基因突变导致了他们的脑部功能紊乱。 PTEN基因的突变可引发乳腺、结肠、甲状腺以及其他器官发生癌症。在携带该突变的儿童中,有10%患有自闭症。而在携带可导致某些类型的脑癌、肾癌以及若干器官(包括脑部)大型肿瘤的突变基因的儿

Nature:科学家发现30种常见癌症DNA秘密 助开发新疗法

  研究人员已解开30种最常见癌症的DNA秘密,使williamhill asia 离了解它们的起因更近一步。癌症是由DNA突变造成的。 科学家有望了解肿瘤DNA的遗传密码模式,例如由吸烟造成的肺癌等。但其他原因令人吃惊,例如科学家认为一种有助于williamhill asia 抵抗传染病的蛋白质造成癌症等。每种癌症有至少两个遗传密码模式,但乳腺癌但有5个,肝癌有6个。 据国外媒体9月2日报道,英国科学家在抗癌的道路上有了一项意义深

Nature:“长的非编码RNAs”在去势抵抗性前列腺癌中上调

几个“长的非编码RNAs”(lncRNAs) 已知在前列腺癌中过度表达。Michael Rosenfeld及同事研究了这些“长的非编码RNAs”中的两个的机制功能和生物功能,它们分别是PRNCR1 和 PCGEM1。二者都被发现依赖于特定的翻译后修饰与雄性激素受体(AR)发生相互作用,增强与AR结合在一起的增强子向目标基因启动子的成环作用(looping),导致基因表达增强。它们还增强前列腺癌细胞

Nat Biotechnol:科学家利用干细胞制造大量可靶向肿瘤的免疫细胞

近日,纪念斯隆-凯特林癌症中心的科学家发明了一种利用干细胞制造出大量可杀死小鼠体内肿瘤细胞的人免疫细胞的新技术。该技术或能让癌症免疫疗法这种通过激活免疫系统来消灭肿瘤的治疗方法更容易获得实施。相关研究论文刊登在了近期出版的Nature Biotechnology杂志上。【原文下载】 大多数癌症免疫疗法需要从病人血液中分离出T细胞这种免疫细胞。但是,能够杀死特定肿瘤细胞而不